MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells

作者: Zhong Zheng , Peng-Peng Xu , Li Wang , Hui-Jin Zhao , Xiang-Qin Weng

DOI: 10.1186/S13046-017-0551-Z

关键词: Cancer researchTumor progressionImmune systemTumor microenvironmentCell growthCD30B-cell lymphomaChemistryICOS LIGANDCell culture

摘要: MicroRNAs (miRs) are involved in tumor progression by regulating cells and microenvironment. MiR21 is overexpressed diffuse large B-cell lymphoma (DLBCL) its biological impact on microenvironment remains unclear. was assessed quantitative RT-PCR patients with newly diagnosed DLBCL. The mechanism of action miR21 angiogenesis examined vitro B-lymphoma cell lines vivo a murine xenograft model. Serum significantly elevated associated advanced disease stage, International Prognostic Index indicating intermediate-high high-risk, increased angiogenesis. When co-cultured immune endothelial cells, miR21-overexpressing were resistant to chemotherapeutic agents, but sensitive Bcl-2 inhibitor ABT-199, irrespective expression cells. In both co-culture systems Bcl-2positive Bcl-2negative induced inducible co-stimulator (ICOS) regulatory T (Treg) Through crosstalking Treg ICOS ligand (ICOSL), activated, resulting stimulation vessel formation. ABT-199 directly targeted apoptosis inhibited model established subcutaneous injection particularly retarded the growth tumors, consistent induction inhibition As serum oncogenic biomarker lymphoma, indicated sensitivity via ICOS/ICOSL-mediated interaction

参考文章(38)
Arlene H. Sharpe, Gordon J. Freeman, The B7–CD28 superfamily Nature Reviews Immunology. ,vol. 2, pp. 116- 126 ,(2002) , 10.1038/NRI727
Dooyoung Lee, Chanseok Shin, MicroRNA-target interactions: new insights from genome-wide approaches Annals of the New York Academy of Sciences. ,vol. 1271, pp. 118- 128 ,(2012) , 10.1111/J.1749-6632.2012.06745.X
Chiara Dianzani, Rosalba Minelli, Riccardo Mesturini, Annalisa Chiocchetti, Giuseppina Barrera, Sabrina Boscolo, Chiara Sarasso, Casimiro Luca Gigliotti, Daniele Sblattero, Junji Yagi, Josè Maria Rojo, Roberto Fantozzi, Umberto Dianzani, B7h Triggering Inhibits Umbilical Vascular Endothelial Cell Adhesiveness to Tumor Cell Lines and Polymorphonuclear Cells Journal of Immunology. ,vol. 185, pp. 3970- 3979 ,(2010) , 10.4049/JIMMUNOL.0903269
Leticia De Mattos-Arruda, Giulia Bottai, Paolo G. Nuciforo, Luca Di Tommaso, Elisa Giovannetti, Vicente Peg, Agnese Losurdo, José Pérez-Garcia, Giovanna Masci, Fabio Corsi, Javier Cortés, Joan Seoane, George A. Calin, Libero Santarpia, MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients Oncotarget. ,vol. 6, pp. 37269- 37280 ,(2015) , 10.18632/ONCOTARGET.5495
Heounjeong Go, Ji-Young Jang, Pil-Jong Kim, Young-Goo Kim, Soo Jeong Nam, Jin Ho Paik, Tae Min Kim, Dae Seog Heo, Chul-Woo Kim, Yoon Kyung Jeon, MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma. Oncotarget. ,vol. 6, pp. 15035- 15049 ,(2015) , 10.18632/ONCOTARGET.3729
Buyuan Chen, Xinji Chen, Xiwei Wu, Xiaoling Wang, Yingjia Wang, Ting-Yu Lin, Jessica Kurata, Jun Wu, Steven Vonderfecht, Guihua Sun, He Huang, Jiing-Kuan Yee, Jianda Hu, Ren-Jang Lin, Disruption of microRNA-21 by TALEN leads to diminished cell transformation and increased expression of cell–environment interaction genes Cancer Letters. ,vol. 356, pp. 506- 516 ,(2015) , 10.1016/J.CANLET.2014.09.034
Cheng Fang, Dan-Xia Zhu, Hua-Jie Dong, Zhi-Jian Zhou, Yin-Hua Wang, Ling Liu, Lei Fan, Kou-Rong Miao, Peng Liu, Wei Xu, Jian-Yong Li, Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma Annals of Hematology. ,vol. 91, pp. 553- 559 ,(2012) , 10.1007/S00277-011-1350-9